# Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required

Source: https://welltoldgrants.com/grants/rfa-fd-21-021-renewal-elucidating-the-sensorial-and-functional/  
Official notice: https://www.grants.gov/search-results-detail/330941

> Food and Drug Administration offered grants of up to $500,000 (at least $250,000) to the applicants described in the notice. It expected to make one award. Applications closed on March 18, 2021.

| Field | Value |
|---|---|
| Opportunity number | RFA-FD-21-021 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | March 18, 2021 |
| Award ceiling | $500,000 |
| Award floor | $250,000 |
| Expected awards | 1 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Eligible Organizations · University of Queensland Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

## What the grant funds

The purpose of this funding opportunity is to support research relevant to topical semisolid drug products that will help elucidate the relationship between a product's quality attributes and its functional (therapeutic) properties, as well as the impact of product aging on those properties. The goal is to characterize the relevant physicochemical and structural properties of topical semisolid formulations/products to assess (and predict) whether test and reference products that may be compositionally different are likely to provide a comparable sensory experience to a patient (including comparable perceptions of grittiness, silky-smoothness, and cooling sensation) which may impact the therapeutic equivalence of the drug products.

## Questions people ask

### Is RFA-FD-21-021 still open?

No. It closed on March 18, 2021. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required?

Food and Drug Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required?

Closed March 18, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $500,000 each.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.